Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial
American Journal of Psychiatry Nov 13, 2019
Carmi L, Tendler A, Bystritsky A, et al. - Researchers investigated the therapeutic effect of deep transcranial magnetic stimulation (dTMS) for obsessive-compulsive disorder (OCD) in a multicenter double-blind sham-controlled study. They randomly allocated 99 OCD patients at 11 centers to receive treatment with either high-frequency (20 Hz) or sham dTMS; daily treatments were provided following individualized symptom provocation, for 6 weeks. Study completion was reported in 89% of the active treatment group and 96% of the sham treatment group. As per outcomes, significant improvement in OCD symptoms could be achieved via performing high-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex and hence, this may be considered as a potential intervention for patients who do not respond adequately to pharmacological and psychological interventions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries